Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 6 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
6 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 211513-37-0, Jtt-705, Dalcetrapib (jtt-705, ro4607381), Ro4607381, Ro-4607381, Jtt 705

Molecular Formula

C₂₃H₃₅NO₂S

Molecular Weight

389.6 g/mol

InChI Key

YZQLWPMZQVHJED-UHFFFAOYSA-N

FDA UNII

3D050LIQ3H

Dalcetrapib is a cholesteryl ester transfer protein (CETP) inhibitor that can produce an increase in serum HDL-cholesterol levels and a decrease in serum LDL-cholesterol levels. Dalcetrapib is structurally dissimilar from other CETP inhibitors, including torcetrapib, and raises functional HDL by a different mechanism.

1 2D Structure

Dalcetrapib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate

2.1.2 InChI

InChI=1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26)

2.1.3 InChI Key

YZQLWPMZQVHJED-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C

2.2 Other Identifiers

2.2.1 UNII

3D050LIQ3H

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Jtt 705

2. Jtt-705

3. Jtt705

4. Ro-4607381

5. Ro4607381

6. S-(2-((1-(2-ethylbutyl)cyclohexane)carbonylamino)phenyl) 2-methylpropanethioate

2.3.2 Depositor-Supplied Synonyms

1. 211513-37-0

2. Jtt-705

3. Dalcetrapib (jtt-705, Ro4607381)

4. Ro4607381

5. Ro-4607381

6. Jtt 705

7. Jtt705

8. S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate

9. 2-methylpropanethioic Acid S-[2-[1-(2-ethylbutyl)cyclohexylcarboxamido]phenyl] Ester

10. 3d050liq3h

11. Chembl313006

12. S-(2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl) 2-methylpropanethioate

13. S-2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl 2-methylpropanethioate

14. S-[2-({[1-(2-ethylbutyl)cyclohexyl]carbonyl}amino)phenyl] 2-methylpropanethioate

15. Thioisobutyric Acid S-(2-{[1-(2-ethyl-butyl)-cyclohexanecarbonyl]-amino}-phenyl) Ester

16. Rg-1658

17. Dalcetrapib [mi]

18. Dalcetrapib [inn]

19. Dalcetrapib (usan/inn)

20. Dalcetrapib [usan:inn]

21. Dalcetrapib [usan]

22. Dalcetrapib (jtt-705)

23. Unii-3d050liq3h

24. Dalcetrapib [who-dd]

25. Schembl528622

26. Chebi:95001

27. Dalcetrapib, >=97% (hplc)

28. Dtxsid70943475

29. Ex-a092

30. Bcpp000268

31. Hms3656f06

32. Amy21305

33. Zinc3976476

34. Bdbm50092197

35. Mfcd06407886

36. S2772

37. Dalcetrapib Pound Jtt-705 Pound(c)

38. Akos015966940

39. Bcp9000580

40. Ccg-264995

41. Cs-0916

42. Db12181

43. Pb12356

44. S-(2-(1-(2-ethylbutyl)cyclohexane-1-carboxamido)phenyl) 2-methylpropanethioate

45. Ncgc00386198-05

46. Ac-27462

47. As-55940

48. Hy-14950

49. Dalcetrapib (jtt-705; Ro-4607381)

50. Ft-0769704

51. Sw219843-1

52. A25148

53. D09708

54. J-510086

55. Q5210285

56. Brd-k18849474-001-01-0

57. Jtt-705;s-2-(2-ethylbutyl)-2-formamidocyclohexyl 2-methyl-2-phenylpropanethioate

58. S-[2-[1-(2-ethylbutyl)cyclohexanecarbonylamino]-phenyl] 2-methylthiopropionate

59. Propanethioic Acid, 2-methyl-, S-(2-(((1-(2-ethylbutyl)cyclohexyl)carbonyl)amino)phenyl) Ester

2.4 Create Date

2006-07-28

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₃₅NO₂S
Molecular Weight	389.6 g/mol
XLogP3	7.1
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	9
Exact Mass	389.23885053 g/mol
Monoisotopic Mass	389.23885053 g/mol
Topological Polar Surface Area	71.5 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	481
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Lipoprotein deficiency

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Anticholesteremic Agents

Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

ABOUT THIS PAGE

Find Dalcetrapib manufacturers, exporters & distributors on PharmaCompass

Dalcetrapib

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

6 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 177,429

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

3DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?